1. Home
  2. BOXL vs PMCB Comparison

BOXL vs PMCB Comparison

Compare BOXL & PMCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOXL
  • PMCB
  • Stock Information
  • Founded
  • BOXL 1985
  • PMCB 1996
  • Country
  • BOXL United States
  • PMCB United States
  • Employees
  • BOXL N/A
  • PMCB N/A
  • Industry
  • BOXL Telecommunications Equipment
  • PMCB Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • BOXL Telecommunications
  • PMCB Health Care
  • Exchange
  • BOXL Nasdaq
  • PMCB Nasdaq
  • Market Cap
  • BOXL 5.8M
  • PMCB 5.8M
  • IPO Year
  • BOXL 2017
  • PMCB N/A
  • Fundamental
  • Price
  • BOXL $1.86
  • PMCB $0.90
  • Analyst Decision
  • BOXL Buy
  • PMCB
  • Analyst Count
  • BOXL 3
  • PMCB 0
  • Target Price
  • BOXL $5.00
  • PMCB N/A
  • AVG Volume (30 Days)
  • BOXL 21.5K
  • PMCB 38.8K
  • Earning Date
  • BOXL 08-13-2025
  • PMCB 08-11-2025
  • Dividend Yield
  • BOXL N/A
  • PMCB N/A
  • EPS Growth
  • BOXL N/A
  • PMCB N/A
  • EPS
  • BOXL N/A
  • PMCB 3.19
  • Revenue
  • BOXL $113,560,000.00
  • PMCB N/A
  • Revenue This Year
  • BOXL N/A
  • PMCB N/A
  • Revenue Next Year
  • BOXL N/A
  • PMCB N/A
  • P/E Ratio
  • BOXL N/A
  • PMCB $0.28
  • Revenue Growth
  • BOXL N/A
  • PMCB N/A
  • 52 Week Low
  • BOXL $1.06
  • PMCB $0.80
  • 52 Week High
  • BOXL $10.65
  • PMCB $2.42
  • Technical
  • Relative Strength Index (RSI)
  • BOXL 41.87
  • PMCB 41.85
  • Support Level
  • BOXL $1.98
  • PMCB $0.84
  • Resistance Level
  • BOXL $2.43
  • PMCB $0.95
  • Average True Range (ATR)
  • BOXL 0.18
  • PMCB 0.07
  • MACD
  • BOXL -0.03
  • PMCB -0.00
  • Stochastic Oscillator
  • BOXL 3.39
  • PMCB 39.96

About BOXL Boxlight Corporation

Boxlight Corp is a technology company that develops, sells, and services interactive solutions predominantly for the education market but also for the corporate and government sectors. The company currently designs, produces, and distributes interactive technologies, including interactive and non-interactive flat panel displays, LED video walls, media players, classroom audio and campus communication, cameras, and other peripherals for the education market and non-interactive solutions including flat panels, LED video walls, and digital signage. The company also distributes science, technology, engineering, and math (or STEM) products, including 3D printing and robotics solutions and a portable science lab.

About PMCB PharmaCyte Biotech Inc.

PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.

Share on Social Networks: